pH-responsive biomimetic liposomes enhance targeted immunotherapy of bladder cancer.
The study demonstrated that MELP could directly target the FGFR receptor to trigger ferroptosis in bladder cancer cells through the JAK2-STAT3-GPX4 signaling pathway, as well as promote macrophage polarization and dendritic cell maturation in vitro, thereby stimulating antitumor immune responses.